14-59538082-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001164399.2(CCDC175):​c.1564G>A​(p.Glu522Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000261 in 1,532,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000022 ( 0 hom. )

Consequence

CCDC175
NM_001164399.2 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.18

Publications

0 publications found
Variant links:
Genes affected
CCDC175 (HGNC:19847): (coiled-coil domain containing 175)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10030094).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC175NM_001164399.2 linkc.1564G>A p.Glu522Lys missense_variant Exon 13 of 20 ENST00000537690.7 NP_001157871.1 P0C221

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC175ENST00000537690.7 linkc.1564G>A p.Glu522Lys missense_variant Exon 13 of 20 5 NM_001164399.2 ENSP00000453940.1 P0C221
CCDC175ENST00000281581.5 linkc.1564G>A p.Glu522Lys missense_variant Exon 13 of 20 5 ENSP00000452964.1 A0A0A0MTQ8

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152130
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000217
AC:
3
AN:
1380216
Hom.:
0
Cov.:
28
AF XY:
0.00000147
AC XY:
1
AN XY:
681384
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31502
American (AMR)
AF:
0.00
AC:
0
AN:
35644
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35590
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79058
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35046
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5680
European-Non Finnish (NFE)
AF:
0.00000279
AC:
3
AN:
1074830
Other (OTH)
AF:
0.00
AC:
0
AN:
57734
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152130
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41424
American (AMR)
AF:
0.00
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 22, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1564G>A (p.E522K) alteration is located in exon 13 (coding exon 13) of the CCDC175 gene. This alteration results from a G to A substitution at nucleotide position 1564, causing the glutamic acid (E) at amino acid position 522 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
14
DANN
Benign
0.97
DEOGEN2
Benign
0.0091
T;T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.65
T;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.10
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.9
L;.
PhyloP100
1.2
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.5
N;N
Sift
Benign
0.14
T;T
Sift4G
Uncertain
0.059
T;T
Vest4
0.17
MVP
0.030
ClinPred
0.099
T
GERP RS
3.1
Varity_R
0.067
gMVP
0.18
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1332181713; hg19: chr14-60004800; API